Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study
Journal for ImmunoTherapy of Cancer · 2024-09 · 12 (9) · e009348
DOI: 10.1136/jitc-2024-009348 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 03.09.2024. Verfasst von Guanchao Ye und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Deep Learning, Lung Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program, National Science Foundation for Young Scientists of China, Wuhan Science and Technology Bureau Knowledge Innovation Special Project.
Abstract (Originalsprache)
Objectives
Although neoadjuvant immunochemotherapy has been widely applied in non-small cell lung cancer (NSCLC), predicting treatment response remains a challenge. We used pretreatment multimodal CT to explore deep learning-based immunochemotherapy response image biomarkers.
Methods
This study retrospectively obtained non-contrast enhanced and contrast enhancedbubu CT scans of patients with NSCLC who underwent surgery after receiving neoadjuvant immunochemotherapy at multiple centers between August 2019 and February 2023. Deep learning features were extracted from both non-contrast enhanced and contrast enhanced CT scans to construct the predictive models (LUNAI-uCT model and LUNAI-eCT model), respectively. After the feature fusion of these two types of features, a fused model (LUNAI-fCT model) was constructed. The performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. SHapley Additive exPlanations analysis was used to quantify the impact of CT imaging features on model prediction. To gain insights into how our model makes predictions, we employed Gradient-weighted Class Activation Mapping to generate saliency heatmaps.
Results
The training and validation datasets included 113 patients from Center A at the 8:2 ratio, and the test dataset included 112 patients (Center B n=73, Center C n=20, Center D n=19). In the test dataset, the LUNAI-uCT, LUNAI-eCT, and LUNAI-fCT models achieved AUCs of 0.762 (95% CI 0.654 to 0.791), 0.797 (95% CI 0.724 to 0.844), and 0.866 (95% CI 0.821 to 0.883), respectively.
Conclusions
By extracting deep learning features from contrast enhanced and non-contrast enhanced CT, we constructed the LUNAI-fCT model as an imaging biomarker, which can non-invasively predict pathological complete response in neoadjuvant immunochemotherapy for NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
- Department of Radiology, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
- Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
- Clinical Data Science, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
- Department of Radiation Oncology (Maastro), GROW School of Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
ORCID-Profile: Zhenwei Shi
Förderung
- National Key Research and Development Program
- National Science Foundation for Young Scientists of China
- Wuhan Science and Technology Bureau Knowledge Innovation Special Project
- International Cooperation Project of Hubei Provincial Department of Science and Technology
Zitieren
APA
Ye, G., Wu, G., Qi, Y., Li, K., Wang, M., Zhang, C., Li, F., Wee, L., Dekker, A., Han, C., Liu, Z., Liao, Y., & Shi, Z. (2024). Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study. Journal for ImmunoTherapy of Cancer, 12(9), e009348. https://doi.org/10.1136/jitc-2024-009348
Vancouver
Ye G, Wu G, Qi Y, Li K, Wang M, Zhang C, et al. Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study. Journal for ImmunoTherapy of Cancer. 2024;12(9):e009348. doi:10.1136/jitc-2024-009348
BibTeX
@article{Ye2024,
author = {Ye, Guanchao and Wu, Guangyao and Qi, Yu and Li, Kuo and Wang, Mingliang and Zhang, Chunyang and Li, Feng and Wee, Leonard and Dekker, Andre and Han, Chu and Liu, Zaiyi and Liao, Yongde and Shi, Zhenwei},
title = {Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {9},
pages = {e009348},
doi = {10.1136/jitc-2024-009348}
}
EUVIMED